AbCellera Biologics Inc Equity-NMS: ABCL

$2.09 0 (April 5, 2025)

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$2.09
Open :$2.02
Today's high :$2.1
Today's low :$1.93
52W low :$1.93
52W high :$4.7499
EPS(TTM): :-0.55
Shares O/S :297.99 M
Market cap :622.79 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
AbCellera Biologics Inc $2.09 +0% - 622.79M

Frequently Asked Questions

What is the share price of AbCellera Biologics Inc today?

AbCellera Biologics Inc (ABCL) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About AbCellera Biologics Inc

AbCellera Biologics Inc. discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and endocrine conditions, and autoimmune disorders. The Company’s engine integrates technology, data science, infrastructure, and interdisciplinary teams to solve the antibody discovery problems. The Company has developed technology platforms to unlock drug classes, targets, and modalities, including transmembrane proteins, T-cell engagers, and peptide-MHCs. The Company is focused on advancing an internal pipeline of programs and collaborating on drug development programs with partners. Its first two preclinical programs in its internal pipeline are ABCL575 and ABCL635. ABCL635 is an antibody-drug candidate against an undisclosed target with an indication in metabolic and endocrine conditions. ABCL575 targets OX40 ligand and is being developed as a therapy for the treatment of atopic dermatitis and other indications of autoimmunity and inflammation.